The Keith Michael Andrus Cardiac Research Award was made in honor of its namesake to remember Keith’s legacy and to help advance our understanding and treatment of cardiomyopathy associated with FA. Proposals for this award should focus on advancing understanding and/or treatment of the cardiac involvement in FA.
Maximum Budget (USD): $125,000 per year for 1 or 2 years
FARA accepts letters of intent for projects that fall within FARA’s research priorities as General Research Grants twice a year. In addition to the General Research Grant, FARA funds grants either targeted to focused areas of research or aimed at nurturing young investigators.
All applications must be submitted using FARA’s grant submission portal. This includes a lay summary of the project, budget and a timeline with detailed milestones. The project description, Data Management and Sharing Plan, curriculum vitae/biosketch of each of the key investigators, letters of support, and other relevant documents must be submitted as PDF files.
Click here for special application requirements for the Award for Innovative Mindset.
Project Description
The description of the project (excluding references to literature) should not exceed 10 pages, which includes the specific aims, background, preliminary data, and research plan, plus a brief statement on the suitability of the scientific environment and the availability of the necessary resources/equipment for the proposed research. This page limit excludes references and applies to grants less than $300,000. Larger grants do not have page number restrictions. All grant proposals must provide adequate detail for reviewer evaluation.
Data Management and Sharing Plan
FARA is committed to making the results and outputs of FARA-funded research available to researchers through effective and efficient data management and data sharing practices, and improving the reproducibility and reliability of research findings. Please read the FARA Notice for Data Management and Sharing. Under the DMS Notice, FARA requires researchers to prospectively plan for how scientific data will be preserved and shared through submission of a Data Management and Sharing Plan (DMS Plan). The DMS Plan will be reviewed as part of the FARA grant review process and upon FARA approval, FARA expects researchers and institutions to implement data management and sharing practices as described.
Budget
A detailed budget must be submitted with all proposals, including a justification of all requested expenses. Allowable expenses are: personnel costs/salary with fringe benefits, laboratory reagents and supplies, equipment, animal expenses, publication costs, investigator travel to meetings and conferences and to facilitate collaborations, patient expenses directly related to study and not reimbursable by third party insurers, and patient travel. Expenses that will not be awarded include: indirect costs/overhead, supplementing a postdoc fellowship/research award stipend with another FARA grant, memberships in scientific societies. Budget justification for investigator travel to meetings, conferences and to facilitate collaborations must include the destination, number of people traveling and dates or duration of stay for all anticipated travel, and clearly state how the travel is directly related to the proposed research. Budget limits for each grant type must be met. However, for General Research Grant applications, budgets exceeding 125,000/year will be considered if adequately justified, for example in the case of collaborations involving multiple PIs. The maximum direct salary that can be requested cannot exceed the NIH salary cap for 100% effort. The maximum allowable expense for travel cost is $3000/year. The max allowable expense for publication cost is $2000/year. The maximum allowable expense for data sharing and management cost is $3000/year.
For Postdoctoral Fellowships and Awards, the trainee is required to contribute at least 75% effort to the proposed work. The maximum direct salary that can be requested cannot exceed the NIH stipend level for 100% effort. If the trainee is contributing less than 100% effort then the stipend request must be reduced to correspond to this effort. For example, if the trainee’s effort is 85%, then the stipend requested can be no more than 85% of the appropriate NIH stipend level.
For Clinician Scientist Development Awards, the PI is required to contribute at least 50% effort to the proposed work.
For Graduate Research Fellowships, the only allowable budget items are the graduate student’s salary/stipend plus applicable fringe benefits (including health insurance) and tuition costs and fees that are not already covered by the institution.
If funded, the amount approved by FARA may be different from the requested budget. This change could be as a result of the LOI reviews and/or the full application reviews, or it may be a decision made by FARA when the award is approved.
Milestones
All projects must have objective milestones that are clearly communicated. We appreciate that some projects, especially those that are more basic-science-oriented, might need to have milestone adjustments based on specific experimental outcomes. If the proposal is funded, FARA will utilize the proposed milestones for scheduling progress reports and monitoring the project.
Human Subjects
If human subjects are used in the proposed study, the study must be approved by the Institutional Review Board (IRB) or equivalent. Full funding will not be provided until proof of IRB approval is demonstrated to FARA. Human subjects studied during research conducted under a FARA grant are under no circumstances a responsibility of FARA.
Animal Research
If animals are used, the proposed study must be approved by the Institutional Animal Care and Use Committee (IACUC), or equivalent, indicating that appropriate precautions have been taken to assure that proper treatment, care, and humane conditions are provided.
Other Documents
This can include all supporting materials such as appendices, institutional transmittal forms, letters of support, etc.
All grant applications submitted to FARA undergo a rigorous and confidential review procedure that is overseen by the FARA Scientific Review Committee (SRC).
All FARA grantees must submit annual scientific and financial reports using FARA’s grant submission portal. For Graduate Research Fellowships, a yearly statement of continuing support by the mentor is also required. The required frequency of reports will be stated in the formal funding agreement with FARA. Each report must be submitted to the portal as a PDF file.
Continuation funding will not be provided until all required progress reports are received and reviewed by the FARA SRC, and approved for funding by the FARA Executive Committee.
Any rebudgeting of funds requires prior FARA approval. Please submit rebudgeting requests by email at grants@curefa.org indicating the amount to be rebudgeted, spending categories involved and an explanation of why the rebudgeting is needed.
FARA also encourages investigators to present their FARA-funded research at least once during the course of their grant at the FARA Forum, on a mutually agreed upon date. The Forum is a monthly webinar open to FARA grant awardees and the FARA Scientific Advisory Board and it is held on the second Tuesday of every month.
While FARA does not publish a scoring rubric, successful projects share several strong, consistent traits:
✅ 1. Alignment With FARA Research Priorities
Applications must clearly map to at least one of the priority areas above. Reviewers look for explicit justification of how the project addresses FA disease mechanisms or therapeutic pathways. Friedreich's Ataxia Research Alliance
Success tip: In your narrative, tie your aims directly to FARA-listed priorities and explain why they are critical gaps in FA research.
✅ 2. Clear, Testable Hypothesis and Scientific Rationale
Grants should articulate a strong scientific question with a hypothesis grounded in existing literature and preliminary evidence. Even when preliminary data are limited (especially for AIM awards), the rationale must be compelling.
Success tip: Present a coherent mechanistic story with well-justified hypotheses that reviewers can easily evaluate.
✅ 3. Feasibility and Realistic Experimental Plan
FARA awards are modest in duration and budget relative to large NIH grants. Reviewers prioritize projects with clearly defined milestones, achievable aims, and feasible timelines within the funding period. Friedreich's Ataxia Research Alliance
Success tip: Include contingency plans and measurable endpoints tied to specific timelines.
✅ 4. Innovation With Therapeutic Impact Potential
Especially for mechanisms like the Award for Innovative Mindset (AIM), FARA prioritizes high-risk, high-reward approaches that deviate from incremental advances. Friedreich's Ataxia Research Alliance
Success tip: Explain how the work could create new research directions, tools, or drug targets for FA.
✅ 5. Relevance to Disease and Potential Translation
Projects that bridge discovery biology to translational endpoints — such as biomarker development, clinical measures, or preclinical efficacy — are viewed as more impactful. Friedreich's Ataxia Research Alliance
Success tip: In clinical or translational proposals, emphasize how outcomes inform therapeutic development or clinical trial design.
✅ 6. Investigator Experience and Environment
For career and fellowships (e.g., Postdoctoral, Clinician Scientist, Graduate Research Fellowship), reviewers consider:
Investigator’s track record and productivity
How mentorship and environment support success
Clear professional development plan tied to FA research goals Friedreich's Ataxia Research Alliance
Success tip: Include mentor letters that describe training and career milestone support.
✅ 7. Clear Budget Justification
FARA expects budgets that are strongly tied to project activities with no unrelated costs. Crafting a budget narrative that matches each aim increases confidence in feasibility. Friedreich's Ataxia Research Alliance
✅ 8. Engagement With FARA Community
FARA encourages collaboration, participation in forums, and engagement with the FA research community. Although not a formal requirement, active engagement signals commitment and networking that can strengthen applications. Friedreich's Ataxia Research Alliance
Before submission:
Read the latest FARA Grant Priorities page and match your aims directly to them. Friedreich's Ataxia Research Alliance
Contact FARA staff (e.g., grants@curefa.org) with questions about fit or clarifications. Friedreich's Ataxia Research Alliance
Select the grant type that matches the scale and scope of your research (e.g., AIM for innovative ideas vs. General Research for standard studies). Friedreich's Ataxia Research Alliance
Proposal drafting:
Start with a concise summary that expresses significance and translational relevance.
Define specific aims with measurable endpoints and tie them to FA pathophysiology or therapy development.
Use figures, timelines, and tables to clarify experimental design and deliverables.
Review readiness:
Ask for internal feedback from colleagues familiar with rare disease funding.
Keep lay summaries clear — reviewers often include clinicians or patient advocates.
Projects unrelated to FA biology or therapy development. Friedreich's Ataxia Research Alliance
Incremental work lacking innovation (especially under AIM). Friedreich's Ataxia Research Alliance
| Predictor | Why It Matters |
|---|---|
| Aligns with FARA research priorities | Ensures eligibility and relevance Friedreich's Ataxia Research Alliance |
| Strong hypothesis and rationale | Foundation of scientific merit |
| Feasible and detailed plan | Essential for trust in deliverability Friedreich's Ataxia Research Alliance |
| Innovation and translational emphasis | High impact potential Friedreich's Ataxia Research Alliance |
| Investigator experience & mentoring plan | Supports execution and career growth Friedreich's Ataxia Research Alliance |
| Justified budget | Demonstrates efficient use of funds |
Growing and developing the FA research community is a priority for FARA. As such, FARA encourages applications from junior investigators and young clinicians. Reviewers consider the investigator’s career stage and will review the grant application with this information in mind. For Graduate Research Fellowships, Clinician Scientist Development Awards, Postdoctoral Fellowships and Postdoctoral Research Awards, this PDF file must also include a 1-2 page personal statement of career goals and how the proposed research and research training environment will facilitate achieving these goals. In addition, a mentorship plan developed jointly by the postdoctoral scholar and mentor(s) must be included, as well as CVs/biosketches and letters of support from mentor(s). For Clinician Scientist Development Awards, a letter of support from the Department Chair, confirming at least 50% protected time and outlining other responsibilities (such as clinic and on-call time) is required. If junior investigators would like support through the application process or general advice on grant writing, they may contact grants@curefa.org.
FARA will accept grant submissions from industry partners who have a demonstrated participation in the FA research community and are advancing therapeutic candidates for FA. FARA requires that a letter of intent (LOI) be submitted prior to the submission of a grant proposal. All projects/requests should be:
FARA will also accept proposals for direct patient-related expenses for clinical studies.
Letter of Intent and Applications
Grant Review Process
In addition to scientific review, a grant application from a for-profit entity will also be reviewed for its commercial viability by FARA board members.
Sponsor Institute/Organizations: Friedreich's Ataxia Research Alliance
Sponsor Type: Corporate/Non-Profit
Address: 533 W. Uwchlan Ave, Downingtown, PA 19335
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Apr 15, 2026
Apr 15, 2026
$125,000
Affiliation: Friedreich's Ataxia Research Alliance
Address: 533 W. Uwchlan Ave, Downingtown, PA 19335
Website URL: https://www.curefa.org/research/grant-program/grant-type/#keith
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.